Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.
Am J Hematol. 2024 Jun 11. doi: 10.1002/ajh.27414. Online ahead of print.
Am J Hematol. 2024.
PMID: 38860642
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Part 1 results of a phase I/II study.
Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Spiliopoulou V, Kostopoulos IV, Syrigou RE, Eleutherakis-Papaiakovou E, Gkolfinopoulos S, Tsitsilonis OE, Kastritis E, Dimopoulos MA.
Terpos E, et al. Among authors: syrigou re.
Haematologica. 2024 Feb 15. doi: 10.3324/haematol.2023.284347. Online ahead of print.
Haematologica. 2024.
PMID: 38356458
Free article.
Item in Clipboard
Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies.
Kastritis E, Theodorakakou F, Ntanasis-Stathopoulos I, Spiliopoulou V, Solia E, Malandrakis P, Syrigou R, Kokkali N, Migkou M, Eleutherakis-Papaiakovou E, Fotiou D, Roussou M, Kanellias N, Gavriatopoulou M, Terpos E, Dimopoulos MA.
Kastritis E, et al. Among authors: syrigou r.
Hemasphere. 2023 Nov 3;7(11):e975. doi: 10.1097/HS9.0000000000000975. eCollection 2023 Nov.
Hemasphere. 2023.
PMID: 37936678
Free PMC article.
No abstract available.
Item in Clipboard
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
Ntanasis-Stathopoulos I, Filippatos C, Gavriatopoulou M, Malandrakis P, Eleutherakis-Papaiakovou E, Spiliopoulou V, Syrigou RE, Theodorakakou F, Fotiou D, Migkou M, Roussou M, Kastritis E, Dimopoulos MA, Terpos E.
Ntanasis-Stathopoulos I, et al. Among authors: syrigou re.
Diseases. 2023 Sep 18;11(3):123. doi: 10.3390/diseases11030123.
Diseases. 2023.
PMID: 37754319
Free PMC article.
Item in Clipboard
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.
Kastritis E, Gavriatopoulou M, Solia E, Theodorakakou F, Spiliopoulou V, Malandrakis P, Ntanasis-Stathopoulos I, Migkou M, Kokkali N, Eleutherakis-Papaiakovou E, Syrigou R, Fotiou D, Terpos E, Dimopoulos MA.
Kastritis E, et al. Among authors: syrigou r.
Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):844-849. doi: 10.1016/j.clml.2023.07.013. Epub 2023 Aug 1.
Clin Lymphoma Myeloma Leuk. 2023.
PMID: 37599164
Item in Clipboard
Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment.
Delialis D, Georgiopoulos G, Aivalioti E, Mavraganis G, Dimopoulou AM, Sianis A, Aggelidakis L, Patras R, Petropoulos I, Ioannou S, Syrigou R, Chatzidou S, Kanakakis I, Stellos K, Stamatelopoulos K.
Delialis D, et al. Among authors: syrigou r.
Hellenic J Cardiol. 2022 Jul-Aug;66:26-31. doi: 10.1016/j.hjc.2022.05.011. Epub 2022 Jun 4.
Hellenic J Cardiol. 2022.
PMID: 35667617
Free article.
Item in Clipboard
Cite
Cite